Keywords: Merck & Co, Idera Pharma, vacine candidates selection

Merck & Co selects Idera vaccine candidates

Article | 10 January 2012

Print This

Idera Pharmaceuticals (Nasdaq: IDRA) says that US drugs giant that Merck & Co (NYSE: MRK) has selected several novel Toll-like ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in